0001551986-18-000029.txt : 20180910
0001551986-18-000029.hdr.sgml : 20180910
20180910174920
ACCESSION NUMBER: 0001551986-18-000029
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180907
FILED AS OF DATE: 20180910
DATE AS OF CHANGE: 20180910
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Laumas Sandeep
CENTRAL INDEX KEY: 0001721664
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37797
FILM NUMBER: 181063564
MAIL ADDRESS:
STREET 1: 8480 HONEYCUTT RD, SUITE 200
CITY: RALEIGH
STATE: NC
ZIP: 27615
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INNOVATE BIOPHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001551986
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8480 HONEYCUTT ROAD
STREET 2: SUITE 120
CITY: RALEIGH
STATE: NC
ZIP: 27615
BUSINESS PHONE: 919-275-1933
MAIL ADDRESS:
STREET 1: 8480 HONEYCUTT ROAD
STREET 2: SUITE 120
CITY: RALEIGH
STATE: NC
ZIP: 27615
FORMER COMPANY:
FORMER CONFORMED NAME: Monster Digital, Inc.
DATE OF NAME CHANGE: 20150930
FORMER COMPANY:
FORMER CONFORMED NAME: Tandon Digital, Inc.
DATE OF NAME CHANGE: 20120611
4
1
wf-form4_153661614405437.xml
FORM 4
X0306
4
2018-09-07
0
0001551986
INNOVATE BIOPHARMACEUTICALS, INC.
INNT
0001721664
Laumas Sandeep
C/O INNOVATE BIOPHARMACEUTICALS, INC.,
8480 HONEYCUTT ROAD, SUITE 120
RALEIGH
NC
27615
1
1
0
0
Executive Chairman
Common stock
2018-09-07
4
P
0
500
6.10
A
2000
D
Common stock
758373
I
By Bearing Circle Capital LLC
Due to an administrative error, the holdings reported on Dr. Laumas's prior Form 4 filing were understated by 750 shares. This balance now reflects the correct amount of Dr. Laumas's direct holdings.
These shares are held by Bearing Circle Capital LLC. Dr. Laumas is affiliated with Bearing Circle Capital LLC and has voting and investment power over the shares held by Bearing Circle Capital LLC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for the purposes of Section 16 or for any other purpose.
/s/ Kendyle Woodard, as Attorney-in-Fact
2018-09-10